Theon Pharmaceuticals Limited
Theon Pharmaceuticals Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 2005, the company has established itself as a leader in the development and manufacturing of high-quality injectable pharmaceuticals, particularly in the areas of oncology and anaesthesia. Theon Pharmaceuticals is renowned for its commitment to innovation, offering a diverse portfolio of products that meet stringent regulatory standards. Their unique formulations and advanced delivery systems set them apart in a competitive market. With a strong focus on research and development, Theon has achieved significant milestones, including numerous product approvals and partnerships that enhance its market position. As a trusted name in the pharmaceutical sector, Theon Pharmaceuticals continues to contribute to global healthcare advancements.
DitchCarbon Score
How does Theon Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Theon Pharmaceuticals Limited's score of 4 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Theon Pharmaceuticals Limited's reported carbon emissions
Theon Pharmaceuticals Limited, headquartered in India, currently does not have publicly available data regarding its carbon emissions or specific climate commitments. As such, there are no reported figures for emissions in kg CO2e, nor are there defined reduction targets or initiatives outlined in their sustainability strategy. In the absence of specific emissions data, it is important to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action. This often includes commitments to reduce greenhouse gas emissions across various scopes, including Scope 1 (direct emissions), Scope 2 (indirect emissions from energy), and Scope 3 (indirect emissions from the supply chain). Theon Pharmaceuticals may be engaging in similar efforts, but without concrete data or commitments, it is difficult to assess their current standing in terms of carbon emissions and climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Theon Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
